Monday, September 22, 2025
HomeIndustriesBiotechnology

Biotechnology

Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy

Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. announced positive interim results from the ongoing single ascending dose part of the Phase 1 study of...

AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

AmerisourceBergen, a global healthcare company, announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with...

CPC Launches Biopharma’s Largest Aseptic Connector

CPC, part of Dover and a leading manufacturer of connection technologies used in biopharmaceutical processing, announced the launch of its AseptiQuik W Series, the industry's...

Asahi Kasei Bioprocess America and GeminiBio Enter Strategic Partnership to Advance Application of Inline Buffer Formulation and Streamline Biopharmaceutical Manufacturing Processes

Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio have entered into a strategic partnership to advance the...

Meridian Bioscience Announces FDA Clearance for Innovative Curian Shiga Toxin Assay

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced that the United States Food and Drug...
0FansLike
0FollowersFollow
spot_img

Hot Topics